World Stroke Day 2022
World Stroke Day 2022 World Stroke Day is approaching! At Moleac, we are committed to increase stroke awareness and to help stroke patients to Reconnect with their lives. Check our Stroke Exercise eBook and access a large set of exercises with various intensities...
NeuroAiD has shown favourable outcome in patients suffering from spinal cord injuries
NeuroAiD has shown favourable outcome in patients suffering from spinal cord injuries Singapore, June 6, 2022, Moleac is pleased to announce the release of the results of the SATURN study1 published online in the Journal of Spinal Cord Medicine. SATURN study aimed at...
NeuroAiD™II holds promise as a safe add-on therapy to standard Alzheimer Disease symptomatic treatments and may have a disease modifying effect by delaying disease progression
NeuroAiD™II holds promise as a safe add-on therapy to standard Alzheimer Disease symptomatic treatments and may have a disease modifying effect by delaying disease progression SINGAPORE, January 22 Moleac is pleased to announce the release of the ATHENE study results,...
Moleac Pte Ltd wins SBR National Business Award for Pharmaceuticals
Moleac Pte Ltd wins SBR National Business Award for Pharmaceuticals SINGAPORE, MAY 2021 Moleac, a biopharmaceutical company based in Singapore, wins SBR National Business Award for Pharmaceuticals. Moleac is dedicated in finding, developing, and commercializing new...
